- Interventional
- Observational
- Expanded Access
Digital Trials Market size was valued at USD 7.3 billion in 2022 and it is expected to grow to USD 14.2 billion growing at a 7.4% CAGR from 2023 to 2029. Digital trials are the information that includes data, results, information, discoveries, invention, and method resulting from clinical trial studies by personnel performance and invigilator, but except personnel data from medical records. A critical phase in clinical research leads to generating high-quality data reliable and statical data from clinical trials to manage all the data Digital Trial Management tools are used. Various study designs are segmented into Interventional Cardiology , Observational, and expanded access are used to collect information regarding clinical trials. The rapid increase in the development of novel drugs for medications of various diseases and the increase in technology in the digitalization of clinical data is the major factor driving the market. Due to covid outbreak, clinical trials on drugs and vaccines are increasing rapidly to lower the risk through various chronic and acute diseases which result in to increase in demand for digital trails information. Expanded access is a potential pathway to subdue patients for new drug and vaccine development. The oncology segment dominated the market for Virtual/Decentralized Clinical Trials and accounted for the largest revenue share of 28.4% in 2022, including the clinical trials in cardiovascular chronic diseases accounted second largest revenue share of 24.6% in the same year.
Digital Trials Market Key Developments:
- In January 2023, Curebase launched All-in-One Software and Trial Execution Package to Help Digital Therapeutics Companies Accelerate Clinical Trials
In September 2022, BMS and ConcertAI launch a digital trial solution for oncology. The digital trial solutions are designed to merge well into the clinical workflows of healthcare practices.
Digital Trials Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
7.4%
Largest Market
North America
Fastest Growing Market
Asia Pacific
Digital Trials Market Dynamics
The increasing prevalence of virtual trials of chronic and acute diseases across the world is the major market driver in the Digital Trials Market during the forecast period. With the rise in various diseases around the world the research and development for various novel medications and vaccines increased results the number of trials also increased to collect information is crucial for firms, digital trial data are the most effective way to collect data. Low rate of enrollment poses risk to the success of clinical trial studies they hamper the treatment advances and corresponding benefits to the outcomes which anticipated the boost of virtual clinical trial studies. Hence, this will drive global market growth at a significant rate.
Asia-Pacific Got Significant Share
Digital Trials Market Regional Analysis
Based on regions, the market share is segmented into North America, Asia-pacific, Europe, the Middle East, and the African region. The digital trials market in the Asia Pacific holds a significant revenue share in 2022, and, in the following years, it is predicted to increase rapidly. It is attributed to the increasing number of various acute and chronic diseases and the rapidly growing well-developed healthcare infrastructure. As the increase in the number of various large patient pools enables easy recruitment of candidates for developing digital trials in the region, China and India are the emerging markets for digital trials due to various diseases outbreak and technological infrastructure rise in the digital trial market. North America is holding the major market share in the global market and is expected to dominate the market in the upcoming years due to global key players in this region due to an increase in technological advancement as well as government support. furthermore, key players are using digital tools to meet client needs.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Digital Trials Market Segmentation
By Study Design
By Application
- Peripheral Vascular Disease
- Oncology
- Neurology
- Urology
- Others
By End User
- Hospitals
- Ambulatory Surgical Centers
- Pharmaceutical Companies
- Laboratories
- Others
By Geography
- North America
- Europe
- The Asia Pacific
- Latin America
- MEA
LOCATION
Geography
Frequently Asked Questions
The digital trials market was valued at USD 7.3 billion in 2022 and it is expected to grow at a significant CAGR of 7.4% from 2023 to 2029.
Digital trials are the information that includes data, results, information, discoveries, invention, and method resulting from clinical trial studies by personnel performance and invigilator, but except personnel data from medical records.
The leading players in the Digital Trials Market are ICON plc, Parexel International Corporation, IQVIA, Covance, PRA Health Sciences, LEO Innovation Lab, Medidata, Oracle, CRF Health, Clinical Ink, Medable, Inc., Signant Health, Clinical Ink, Halo Health Systems, and Croprime
Historic years considered for the market study are 2018 through 2022, 2022 is considered as the base year for market estimation, and Seven years forecast is presented from 2023 – 2029.
| 1. Executive Summary |
| 2. Global Digital Trials Market Introduction |
| 2.1.Global Digital Trials Market - Taxonomy |
| 2.2.Global Digital Trials Market - Definitions |
| 2.2.1.Study Design |
| 2.2.2.Application |
| 2.2.3.End User |
| 2.2.4.Region |
| 3. Global Digital Trials Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Digital Trials Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Digital Trials Market By Study Design, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 5.1. Interventional |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Observational |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Expanded Access |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6. Global Digital Trials Market By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 6.1. Peripheral Vascular Disease |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Oncology |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Neurology |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Urology |
| 6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Others |
| 6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7. Global Digital Trials Market By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Ambulatory Surgical Centers |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Pharmaceutical Companies |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Laboratories |
| 7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Others |
| 7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8. Global Digital Trials Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9. North America Digital Trials Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 9.1. Study Design Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Interventional |
| 9.1.2.Observational |
| 9.1.3.Expanded Access |
| 9.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Peripheral Vascular Disease |
| 9.2.2.Oncology |
| 9.2.3.Neurology |
| 9.2.4.Urology |
| 9.2.5.Others |
| 9.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospitals |
| 9.3.2.Ambulatory Surgical Centers |
| 9.3.3.Pharmaceutical Companies |
| 9.3.4.Laboratories |
| 9.3.5.Others |
| 9.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10. Europe Digital Trials Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 10.1. Study Design Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Interventional |
| 10.1.2.Observational |
| 10.1.3.Expanded Access |
| 10.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Peripheral Vascular Disease |
| 10.2.2.Oncology |
| 10.2.3.Neurology |
| 10.2.4.Urology |
| 10.2.5.Others |
| 10.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals |
| 10.3.2.Ambulatory Surgical Centers |
| 10.3.3.Pharmaceutical Companies |
| 10.3.4.Laboratories |
| 10.3.5.Others |
| 10.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11. Asia Pacific (APAC) Digital Trials Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 11.1. Study Design Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Interventional |
| 11.1.2.Observational |
| 11.1.3.Expanded Access |
| 11.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Peripheral Vascular Disease |
| 11.2.2.Oncology |
| 11.2.3.Neurology |
| 11.2.4.Urology |
| 11.2.5.Others |
| 11.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals |
| 11.3.2.Ambulatory Surgical Centers |
| 11.3.3.Pharmaceutical Companies |
| 11.3.4.Laboratories |
| 11.3.5.Others |
| 11.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12. Middle East and Africa (MEA) Digital Trials Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 12.1. Study Design Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Interventional |
| 12.1.2.Observational |
| 12.1.3.Expanded Access |
| 12.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Peripheral Vascular Disease |
| 12.2.2.Oncology |
| 12.2.3.Neurology |
| 12.2.4.Urology |
| 12.2.5.Others |
| 12.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals |
| 12.3.2.Ambulatory Surgical Centers |
| 12.3.3.Pharmaceutical Companies |
| 12.3.4.Laboratories |
| 12.3.5.Others |
| 12.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13. Latin America Digital Trials Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 13.1. Study Design Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Interventional |
| 13.1.2.Observational |
| 13.1.3.Expanded Access |
| 13.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Peripheral Vascular Disease |
| 13.2.2.Oncology |
| 13.2.3.Neurology |
| 13.2.4.Urology |
| 13.2.5.Others |
| 13.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals |
| 13.3.2.Ambulatory Surgical Centers |
| 13.3.3.Pharmaceutical Companies |
| 13.3.4.Laboratories |
| 13.3.5.Others |
| 13.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.ICON plc |
| 14.2.2.Parexel International Corporation |
| 14.2.3.IQVIA |
| 14.2.4.Covance |
| 14.2.5.PRA Health Sciences |
| 14.2.6.LEO Innovation Lab |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
- ICON plc
- Parexel International Corporation
- IQVIA
- Covance
- PRA Health Sciences
- LEO Innovation Lab
- Medidata
- Oracle
- CRF Health
- Clinical Ink
- Medable, Inc.
- Signant Health
- Clinical Ink
- Halo Health Systems
- Croprime